InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results

Bulletin Express

昨天

InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.

The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.

The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1118885332"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118885332\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118885332?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 17:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118885332","market":"hk","top_or_hot":-1,"title":"InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results","media":"Bulletin Express","content":"<p>InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.</p>\n<p>The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>\n<p>The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-11 17:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.</p>\n<p>The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>\n<p>The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"諾誠健華","start_time":0,"source_url":"","article_id":"1118885332","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118885332","pubTimestamp":1786439384,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"诺诚健华计划于2026年8月24日召开董事会会议，以审阅2026年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.\nThe board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.\nThe meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}